Cui J, Tosaki A, Bertelli A A E, Bertelli A, Maulik N, Das D K
Cardiovascular Research Center, University of Connecticut School of Medicine, Farmington, Connecticut, USA.
Drugs Exp Clin Res. 2002;28(1):1-10.
The cardioprotective effects of red wine have been attributed to several polyphenolic antioxidants including resveratrol and proanthocyanidins. The goal of the present study was to determine whether white wines could also provide cardioprotection. Three different white wines (white wine #1, #2 and #3) were chosen for this study. Ethanol-free extracts of the wines were prepared by vacuum evaporation. Rats weighing approximately 200 g were given either 50 mg/kg or 100 mg/kg of each wine extract for 3 weeks. The rats were anesthetized and sacrificed and their hearts were excised for the preparation of isolated working rat heart. All hearts were subjected to 30 min of global ischemia followed by 2 h of reperfusion. Cardiac function including heart rate, left ventricular developed pressure (LVDP), maximum first derivative of developed pressure (LVdp/dtmax), left ventricular systolic pressure (LVSP), left ventricular end diastolic pressure (LVEP), aortic flow (AF) and coronary flow (CF) were continuously monitored and myocardial infarct size was measured at the end of the experiments. The results of our study demonstrated that among the three different white wines, only white wine #2 conferred cardioprotection as evidenced by improved postischemic ventricular recovery compared with controls. The same white wine at a dose of 50 mg/kg also showed improvement in postischemic contractile recovery but the differences compared with controls were not significant. The amount of malondialdehyde production from these hearts was lower than that found in control hearts, indicating reduced formation of reactive oxygen species in white wine #2-treated rats. In vitro studies using a chemiluminescence technique revealed that white wine #2 scavenged both superoxide anions and hydroxyl radicals. The results of our study demonstrate that white wine #2 provided cardioprotection and the cardioprotective effect of the wine can be attributed, at least in part, to its ability to function as an in vivo antioxidant.
红酒的心脏保护作用归因于几种多酚类抗氧化剂,包括白藜芦醇和原花青素。本研究的目的是确定白葡萄酒是否也能提供心脏保护作用。本研究选用了三种不同的白葡萄酒(白葡萄酒#1、#2和#3)。通过真空蒸发制备葡萄酒的无乙醇提取物。给体重约200 g的大鼠分别给予50 mg/kg或100 mg/kg的每种葡萄酒提取物,持续3周。将大鼠麻醉并处死,取出心脏用于制备离体工作大鼠心脏。所有心脏均经历30分钟的全心缺血,随后再灌注2小时。连续监测心脏功能,包括心率、左心室舒张末压(LVDP)、舒张末压的最大一阶导数(LVdp/dtmax)、左心室收缩压(LVSP)、左心室舒张末压(LVEP)、主动脉流量(AF)和冠状动脉流量(CF),并在实验结束时测量心肌梗死面积。我们的研究结果表明,在三种不同的白葡萄酒中,只有白葡萄酒#2具有心脏保护作用,与对照组相比,缺血后心室恢复情况有所改善即可证明。50 mg/kg剂量的同一种白葡萄酒在缺血后收缩恢复方面也有改善,但与对照组相比差异不显著。这些心脏中丙二醛的生成量低于对照组心脏,表明白葡萄酒#2处理的大鼠体内活性氧的形成减少。使用化学发光技术的体外研究表明,白葡萄酒#2能清除超氧阴离子和羟基自由基。我们的研究结果表明,白葡萄酒#2提供了心脏保护作用,且这种葡萄酒的心脏保护作用至少部分可归因于其作为体内抗氧化剂的功能。